Authors:
SALVEN P
LYMBOUSSAKI A
HEIKKILA P
JAASKELASAARI H
ENHOLM B
AASE K
VONEULER G
ERIKSSON U
ALITALO K
JOENSUU H
Citation: P. Salven et al., VASCULAR ENDOTHELIAL GROWTH-FACTORS VEGF-B AND VEGF-C ARE EXPRESSED IN HUMAN TUMORS, The American journal of pathology, 153(1), 1998, pp. 103-108
Authors:
CHEN Y
MI HB
HERRERAMARSCHITZ M
BJELKE B
GROSS J
ANDERSSON K
VONEULER G
Citation: Y. Chen et al., PERINATAL ASPHYXIA INDUCES LONG-TERM CHANGES IN DOPAMINE D-1, D-2, AND D-3 RECEPTOR-BINDING IN THE RAT-BRAIN, Experimental neurology, 146(1), 1997, pp. 74-80
Citation: Y. Liu et G. Voneuler, CA2-3] MK-801 BINDING INDUCED BY GLUTAMATE AND GLYCINE IN THE PRESENCE OF MG2+( AND H+ ANTAGONIZE THE DECREASE OF [H), Neurochemistry international, 28(4), 1996, pp. 401-415
Authors:
OLOFSSON B
PAJUSOLA K
KAIPAINEN A
VONEULER G
JOUKOV V
SAKSELA O
ORPANA A
PETERSSON RF
ALITALO K
ERIKSSON U
Citation: B. Olofsson et al., VASCULAR ENDOTHELIAL GROWTH-FACTOR-B, A NOVEL GROWTH-FACTOR FOR ENDOTHELIAL-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(6), 1996, pp. 2576-2581
Authors:
OLOFSSON B
PAJUSOLA K
VONEULER G
CHILOV D
ALITALO K
ERIKSSON U
Citation: B. Olofsson et al., GENOMIC ORGANIZATION OF THE MOUSE AND HUMAN GENES FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR-B (VEGF-B) AND CHARACTERIZATION OF A 2ND SPLICE ISOFORM, The Journal of biological chemistry, 271(32), 1996, pp. 19310-19317
Authors:
SOUVERBIE F
MO LL
LIU Y
VONEULER G
SUNDSTROM E
Citation: F. Souverbie et al., PHARMACOLOGICAL CHARACTERIZATION OF [H-3] MK-801 BINDING IN THE RAT SPINAL-CORD, European journal of pharmacology, 307(3), 1996, pp. 347-353
Citation: M. Hilleforsberglund et al., PERSISTENT, SPECIFIC AND DOSE-DEPENDENT EFFECTS OF TOLUENE EXPOSURE ON DOPAMINE D-2 AGONIST BINDING IN THE RAT CAUDATE-PUTAMEN, Toxicology, 100(1-3), 1995, pp. 185-194
Citation: G. Voneuler et Pb. Hedlund, REGIONAL AND AGE-DEPENDENT DIFFERENCES IN THE AFFINITY OF DOPAMINE D-2 AGONIST BINDING IN THE RAT-BRAIN, Neurochemistry international, 26(4), 1995, pp. 397-410
Authors:
HILLEFORSBERGLUND M
HEDLUND PB
VONEULER G
Citation: M. Hilleforsberglund et al., EFFECTS OF CGS-21680 IN-VIVO ON DOPAMINE D-2 AGONIST BINDING IN THE RAT-BRAIN, Brain research, 690(1), 1995, pp. 34-40
Authors:
VONEULER G
OGREN SO
ENEROTH P
FUXE K
GUSTAFSSON JA
Citation: G. Voneuler et al., PERSISTENT EFFECTS OF 80 PPM TOLUENE ON DOPAMINE-REGULATED LOCOMOTOR-ACTIVITY AND PROLACTIN SECRETION IN THE MALE-RAT, Neurotoxicology, 15(3), 1994, pp. 621-624
Citation: M. Hilleforsberglund et G. Voneuler, PHARMACOLOGY OF DOPAMINE D-3 RECEPTORS IN THE ISLANDS OF CALLEJA OF THE RAT USING QUANTITATIVE RECEPTOR AUTORADIOGRAPHY, European journal of pharmacology, 261(1-2), 1994, pp. 179-183
Citation: Am. Janson et al., CHRONIC NICOTINE TREATMENT COUNTERACTS DOPAMINE D-2 RECEPTOR UP-REGULATION INDUCED BY A PARTIAL MESO-DIENCEPHALIC HEMITRANSECTION IN THE RAT, Brain research, 655(1-2), 1994, pp. 25-32
Citation: G. Voneuler et Y. Liu, GLUTAMATE AND GLYCINE DECREASE THE AFFINITY OF [H-3] MK-801 BINDING IN THE PRESENCE OF MG2+, European journal of pharmacology. Molecular pharmacology section, 245(3), 1993, pp. 233-239
Authors:
LI XM
FINNMAN UB
VONEULER G
HEDLUND PB
FUXE K
Citation: Xm. Li et al., NEUROMEDIN N IS A POTENT MODULATOR OF DOPAMINE D(2) RECEPTOR AGONIST BINDING IN RAT NEOSTRIATAL MEMBRANES, Neuroscience letters, 155(2), 1993, pp. 121-124